Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers

Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has spread to more than 70 countries worldwide since 2015. Despite active research, there are currently no licensed vaccines or therapeutics. We have previously reported the development of various adenoviral vectored vaccine candidates...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	López-Camacho, C, Kim, Y, Abbink, P, Larocca, R, Huiskonen, J, Barouch, D, Reyes-Sandoval, A
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	MDPI 2019

Những quyển sách tương tự

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
Bằng: César López-Camacho, et al.
Được phát hành: (2019-11-01)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
Bằng: Moorthy, V, et al.
Được phát hành: (2003)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
Bằng: Alharbi, N
Được phát hành: (2014)

Clinical development of Modified Vaccinia virus Ankara vaccines.
Bằng: Gilbert, S
Được phát hành: (2013)

Clinical development of Modified Vaccinia virus Ankara vaccines
Bằng: Gilbert, S
Được phát hành: (2013)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
Bằng: McConkey, S, et al.
Được phát hành: (2003)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
Bằng: Rosario, M, et al.
Được phát hành: (2010)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
Bằng: Schneider, J, et al.
Được phát hành: (1998)

Safety and immunogenicity of IMVAMUNE®, a third-generation vaccine based on the modified vaccinia Ankara (MVA) strain
Bằng: L. F. Stovba, et al.
Được phát hành: (2023-04-01)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
Bằng: Olga Vladimirovna Orlova, et al.
Được phát hành: (2022-09-01)

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
Bằng: Nereida Jiménez de Oya, et al.
Được phát hành: (2022-03-01)

Immunogenicity and efficacy of Zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines
Bằng: López-Camacho, C, et al.
Được phát hành: (2020)

Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity
Bằng: Alharbi, N, et al.
Được phát hành: (2015)

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.
Bằng: Naif Khalaf Alharbi, et al.
Được phát hành: (2015-01-01)

Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Bằng: Lior Nave, et al.
Được phát hành: (2023-08-01)

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
Bằng: Kaïdre Bendjama, et al.
Được phát hành: (2017-09-01)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
Bằng: Goepfert P, et al.
Được phát hành: (2012-09-01)

Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia Ankara-vectored Ebola vaccines: a randomized clinical trial
Bằng: Milligan, I, et al.
Được phát hành: (2016)

Immunogenicity and reactogenicity of novel adenovirus type 26 and modified vaccinia Ankara-vectored Ebola vaccines: A randomized clinical trial
Bằng: Milligan, I, et al.
Được phát hành: (2016)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
Bằng: Mcshane, H, et al.
Được phát hành: (2001)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
Bằng: Behboudi, S, et al.
Được phát hành: (2004)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
Bằng: César López-Camacho, et al.
Được phát hành: (2020-06-01)

Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
Bằng: Valentina Mazzotta, et al.
Được phát hành: (2024-12-01)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
Bằng: Goonetilleke, N, et al.
Được phát hành: (2003)

The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox
Bằng: Mingwang Shen, et al.
Được phát hành: (2024-10-01)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
Bằng: Gilbert, S, et al.
Được phát hành: (1999)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
Bằng: Juan García-Arriaza, et al.
Được phát hành: (2021-08-01)

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate.
Bằng: Jeffrey R Currier, et al.
Được phát hành: (2010-11-01)

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.
Bằng: Sandhya Vasan, et al.
Được phát hành: (2010-01-01)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
Bằng: Hanke, T, et al.
Được phát hành: (1998)

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects.
Bằng: Howles, S, et al.
Được phát hành: (2010)

Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
Bằng: Caroline Staib, et al.
Được phát hành: (2003-04-01)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
Bằng: Volker Sandig, et al.
Được phát hành: (2013-11-01)

Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates
Bằng: Leonie Mayer, et al.
Được phát hành: (2024-11-01)

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
Bằng: Flavia Chiuppesi, et al.
Được phát hành: (2024-02-01)

The Efficacy of Disinfection on Modified Vaccinia Ankara and African Swine Fever Virus in Various Forest Soil Types
Bằng: Franziska Tanneberger, et al.
Được phát hành: (2021-10-01)

Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine
Bằng: Harriet L. Robinson, et al.
Được phát hành: (2018-09-01)

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Bằng: David A Garber, et al.
Được phát hành: (2009-01-01)

Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates
Bằng: Leonie Mayer, et al.
Được phát hành: (2024-12-01)

Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara
Bằng: C. Staib, et al.
Được phát hành: (2000-06-01)